Purpose

The purpose of the study is to evaluate the efficacy of an anti-psychotic medication, Olanzapine, in achieving desired weight gain in patients identified as having Anorexia Nervosa, either restricting or binge/purge subtype. The study will also evaluate the possible beneficial effects of Olanzapine in reducing the severity of the obsessive and/or anxiety symptoms associated with this disorder.

Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number: NCT00260962
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes

Study Activities

Filling Out Forms
Blood Samples

Eligibility

Ages Eligible for Study: 18 Years - Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.

Criteria

Inclusion Criteria:
Those who meet DSM IV criteria of Anorexia Nervosa- either restricting or binge/purge subtype

Location: 
Clinic: Eating Disorders Clinic
Division: Clinical Psychopharmacology

Study chairs or principal investigators:
Evelyn Attia MD, Principal Investigator

Co-investigators:
,